| Bioactivity | Carbutamide (BZ-55) is an orally active and first-generation sulfonylurea with hypoglycemic activity[1]. | ||||||||||||
| In Vivo | Carbutamide is a sulfonylurea derivative that will cause hypoglycemia when administered by mouth to normal animals[2]. | ||||||||||||
| Name | Carbutamide | ||||||||||||
| CAS | 339-43-5 | ||||||||||||
| Formula | C11H17N3O3S | ||||||||||||
| Molar Mass | 271.34 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Kleinsorge H, et al. Carbutamide--the first oral antidiabetic. A retrospect. Exp Clin Endocrinol Diabetes. 1998;106(2):149-51. [2]. ROOT MA, et al. Pharmacology of carbutamide (p-aminophenylsulfonyl butylcarbamide). J Pharmacol Exp Ther. 1957 Apr;119(4):468-78. |